Navigation Links
WeissLaw LLP: The Auspex Pharmaceuticals, Inc. Acquisition by Teva Pharmaceutical Industries Is the Subject of a Legal Investigation
Date:4/3/2015

NEW YORK, April 3, 2015 /PRNewswire/ -- The fairness of the proposed acquisition of Auspex Pharmaceuticals Inc. ("ASPX" or the "Company") by Teva Pharmaceutical Industries ("Teva") is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm.  The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of ASPX for agreeing to sell the Company to Teva.  On March 30, 2015, the Company announced a definitive agreement for Teva to acquire ASPX in a transaction valued at approximately $3.5 billion.  Under the terms of the agreement, ASPX shareholders will receive $101.00 in cash for each ASPX share they own. 

WeissLaw is investigating whether ASPX's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, at least one analyst set a price target of $105.00 per share, or $4.00 above the offer price. 

Given these facts, WeissLaw is investigating whether ASPX's Board acted in the best interests of ASPX's public shareholders by actively shopping the Company to maximize shareholder value prior to entering into the agreement with Teva.  If you own ASPX shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin or Kelly Keenan by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com.  

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.

Attorney Advertising.  Past results do not guarantee a similar outcome.

WeissLaw LLP
Joshua Rubin
Kelly Keenan
1500 Broadway, 16th Floor
New York, NY  10036
T:  212.682.3025
F:  212.682.3010
www.weisslawllp.com
stockinfo@weisslawllp.com

 


'/>"/>
SOURCE WeissLaw LLP
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders
2. Morgan & Morgan Announces Investigation of Auspex Pharmaceuticals, Inc. - ASPX
3. AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
4. Auspex Raises $35 Million And Appoints Industry Veteran Gerald Proehl To Its Board of Directors
5. Auspex Initiates Phase 3 Trial of SD-809 in Huntingtons Disease
6. Columbia Laboratories, Inc. to Become Juniper Pharmaceuticals, Inc.
7. Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge
8. Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd.
9. OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014
10. SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc.
11. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2019)... BEVERLY HILLS, Calif. (PRWEB) , ... November 20, 2019 , ... The Lifedriven Foundation along ... its Mixing it Up with the Champs event from 8 to 11 p.m. on Friday, ... Vegas. This fundraising event will take place on the eve of the PBC Heavyweight Title ...
(Date:11/20/2019)... ... November 20, 2019 , ... “Analysis of the Biofield ... Assay” by Maria Isabel Aguilar has been named No. 1 International Best Seller ... Research, Holistic, Mind-Body Medicine, Allied Health Professions, and Energy Healing. , The aim ...
(Date:11/19/2019)... ... ... “Protective Role of the Biofield Energy Treated Test Formulation on Vital Organs ... Best Seller on Amazon in the USA, Canada, and United Kingdom in 19 categories ... named a hot new release in multiple categories in the USA, Canada, and United ...
Breaking Medicine Technology:
(Date:11/21/2019)... , ... November 21, 2019 , ... ... chall@charteroak.edu; 860-515-3889 , Middlesex Health Care Awarded the Golden Acorn by the Charter ... , The Foundation for Charter Oak State College, Connecticut’s public online college, recently ...
(Date:11/21/2019)... ... November 21, 2019 , ... PointClickCare, ... post-acute care and senior care industry, has named Richter as its 2019 ... Richter and PointClickCare on targeted training activities related to Medicare Patient-Driven Payment ...
(Date:11/20/2019)... ... November 20, 2019 , ... Fujirebio ... and Drug Administration (FDA) clearance of the company’s Lumipulse® G whole PTH Assay ... a hormone secreted by the parathyroid glands; which are four small glands located ...
(Date:11/20/2019)... , ... November 20, 2019 , ... ... Health Specific Biomarkers Using Cell Line Study” by Ariadne Esmene Afaganis has been ... Kingdom in many categories including Nervous System, Molecular Biology, Energy Healing, Public Health, ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... It was ... marathon with a bike ride along the Charles River in Boston. Days later, Bernie ... to him, yet he struggled to know exactly who all of them were. For ...
Breaking Medicine News(10 mins):